Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Feng Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3456-722X; OpenAlex author ID A5101605710. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper

Papers 5

  1. Biodegradable, pH-Sensitive Hollow Mesoporous Organosilica Nanoparticle (HMON) with Controlled Release of Pirfenidone and Ultrasound-Target-Microbubble-Destruc… Co-author DOI 10.7150/thno.36135↗
  2. UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy. Co-author DOI 10.7150/thno.22834↗
  3. Role of microenvironmental periostin in pancreatic cancer progression. Co-author DOI 10.18632/oncotarget.11533↗
  4. Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. Co-author DOI 10.1007/s13277-016-5321-6↗
  5. Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling. Co-author DOI 10.18632/oncotarget.9512↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lizhou Lin · 5 shared papers, 2016–2019 · strength 0.34
  2. Peng Qin · 4 shared papers, 2016–2018 · strength 0.25
  3. Fan Li · 4 shared papers, 2016–2018 · strength 0.25
  4. Lingxi Xing · 3 shared papers, 2016–2017 · strength 0.17
  5. Lianfang Du · 3 shared papers, 2016–2017 · strength 0.17
  6. Jiajie Zhang · 3 shared papers, 2016–2017 · strength 0.17
  7. Lianfang Du · 2 shared papers, 2018–2019 · strength 0.17
  8. Xiangyang Shi · 1 shared paper, 2018 · strength 0.08
  9. Dan Li · 1 shared paper, 2018 · strength 0.08
  10. Yang Liu · 1 shared paper, 2017 · strength 0.06
  11. Yang Liu · 1 shared paper, 2016 · strength 0.05
  12. Liu Yang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.